Study of a Human Metapneumovirus/Respiratory Syncytial Virus mRNA Vaccine Candidate Encapsulated in a Lipid Nanoparticle-based Formulation in Adults Aged 60 Years and Older

NCT06686654 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

1530

Enrollment

INDUSTRY

Sponsor class

Conditions

Human Metapneumovirus Immunization
Respiratory Syncytial Virus Immunization

Interventions

BIOLOGICAL: Investigational hMPV/RSV vaccine
BIOLOGICAL: Investigational hMPV vaccine (monovalent)
BIOLOGICAL: Investigational RSV vaccine (monovalent)
BIOLOGICAL: Licensed RSV Vaccine
BIOLOGICAL: Placebo
BIOLOGICAL: Investigational RSV+hMPV vaccine

Sponsor

Sanofi Pasteur, a Sanofi Company